← back to search

Sharon Hassin‐Baer

Tel Aviv University · IL
Area of research
Neurology · Physiology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Lysosomal Storage Disorders Research, and Genetic Neurodegenerative Diseases.
h-index
44
citations
8,086
works
211
NIH funding
primary concept
email

Recent publications

Is the Subthalamic Nucleus Sleeping Under Nitrous Oxide–Ketamine General Anesthesia?
European Journal of Neuroscience 2025cited by 4position: middledoi
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
The Lancet Neurology 2024cited by 64position: middledoi
GBA1-Associated Parkinson’s Disease Is a Distinct Entity
International Journal of Molecular Sciences 2024cited by 33position: middledoi
Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease?
Parkinsonism & Related Disorders 2024cited by 10position: lastdoi
Long-term safety of medical cannabis in Parkinson's disease: A retrospective case-control study
Parkinsonism & Related Disorders 2023cited by 10position: middledoi
Identification of an early-stage Parkinson’s disease neuromarker using event-related potentials, brain network analytics and machine-learning
PLoS ONE 2022cited by 24position: firstdoi
<i>GALC</i> variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease
medRxiv 2022cited by 3position: middledoi
Deep Brain Stimulation Can Differentiate Subregions of the Human Subthalamic Nucleus Area by EEG Biomarkers
Frontiers in Systems Neuroscience 2021cited by 9position: middledoi
Prevalence of <i>RFC1</i> -mediated spinocerebellar ataxia in a North American ataxia cohort
Neurology Genetics 2020cited by 56position: middledoi
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
Neurobiology of Aging 2020cited by 27position: middledoi
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
Brain 2019cited by 245position: middledoi
A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders
Human Mutation 2019cited by 88position: middledoi
Coupling Between Leg Muscle Activation and EEG During Normal Walking, Intentional Stops, and Freezing of Gait in Parkinson's Disease
Frontiers in Physiology 2019cited by 33position: middledoi
Clinical Experience With Deferiprone Treatment for Friedreich Ataxia
Journal of Child Neurology 2016cited by 58position: lastdoi
Higher Frequency of Certain Cancers in<i>LRRK2</i>G2019S Mutation Carriers With Parkinson Disease
JAMA Neurology 2014cited by 99position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2023–2025)Zvi Israel · Hebrew University of Jerusalem2 papers (2021–2025) · 2 papers (2014–2019) · 2 papers (2023–2024)Daniel Sand · Hewlett-Packard (Israel)2 papers (2021–2022) · 2 papers (2021–2022)Lior Ungar · Neurological Surgery2 papers (2024–2025) · 2 papers (2023–2024)Yonatan Redlich · Hebrew University of Jerusalem2 papers (2023–2024)Zion Zibly · Yale Cancer Center2 papers (2024–2025)Muneer Abu Snineh · Hebrew University of Jerusalem2 papers (2021–2025)Gilad Yahalom · Hebrew University of Jerusalem2 papers (2022–2024) · 2 papers (2021–2022) · 2 papers (2021–2022) · 1 papers (2025–2025)Christopher M. Gómez · Grant Medical Center1 papers (2020–2020) · 1 papers (2024–2024)Ari Zimran · Hebrew University of Jerusalem1 papers (2024–2024)Hagai Bergman · Hebrew University of Jerusalem1 papers (2021–2021)Nir Giladi · Neurim Pharmaceuticals (Israel)1 papers (2014–2014)